4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-15-000229
CIK 0000887247operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:52 PM ET
Size
5.5 KB
Accession
0001387131-15-000229
Insider Transaction Report
Form 4
Moll Thomas
Vice President of Research
Transactions
- Award
Employee Stock Option (right to buy)
2015-01-23+65,050→ 65,050 totalExercise: $5.99Exp: 2025-01-23→ common stock (65,050 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:52 PM ET
- Size
- 5.5 KB